Baricitinib
- Product NDC
- 0002-6885
- 11-digit product format
- 000026885
- Labeler code
- 0002
- Product ID
- 0002-6885_14a2ffe3-1d7e-4d1b-ac44-1698d5f92da4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- baricitinib
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Eli Lilly and Company
- Marketing category
- EMERGENCY USE AUTHORIZATION
- Marketing start
- 2021-12-20
- Substance
- BARICITINIB
- Active strength
- 4 mg/1
- Pharmacologic classes
- Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Baricitinib
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BARICITINIB | 4 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | ISP4442I3Y |
| Rxcui | 2588561 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0002-6885-30 | Baricitinib | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0002-6885 | BARICITINIB TABLET, FILM COATED [ELI LILLY AND COMPANY] | 3 | Current NDC, Legacy NDC, 1 package rows | 20220608_7052c055-fedf-453b-86bc-01f5465eb157.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0002-6885-30 | 00002688530 | 30 TABLET, FILM COATED in 1 BOTTLE (0002-6885-30) | 2021-12-20 | 0000-00-00 | No | No | Current |